相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
Paul L. Nguyen et al.
EUROPEAN UROLOGY (2017)
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Lei Wei et al.
EUROPEAN UROLOGY (2017)
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
Ilka Kristiansen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies
Barbara Uhl et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
Eric A. Klein et al.
JOURNAL OF UROLOGY (2017)
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer
Sadhna Verma et al.
RADIOLOGY (2017)
Molecular biomarkers and prognostic factors for prostate cancer
A. Kretschmer et al.
UROLOGE (2017)
Cell-cycle Progression-score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients
Marco Oderda et al.
UROLOGY (2017)
Molecular biomarkers and prognostic factors for prostate cancer
A. Kretschmer et al.
UROLOGE (2017)
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Peggy Sekula et al.
PLOS ONE (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Prostate cancer: state of the art imaging and focal treatment
D. A. Woodrum et al.
CLINICAL RADIOLOGY (2017)
Tumour heterogeneity poses a significant challenge to cancer biomarker research
Karolina Cyll et al.
BRITISH JOURNAL OF CANCER (2017)
HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors
Valeria Barresi et al.
APMIS (2016)
Clinically available RNA profiling tests of prostate tumors: utility and comparison
Rong Na et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis
Silvia Sommariva et al.
EUROPEAN UROLOGY (2016)
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance
Bruce J. Trock et al.
MODERN PATHOLOGY (2016)
Decipher correlation patterns post prostatectomy: initial experience from 2342 prospective patients
R. B. Den et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk
Eric A. Klein et al.
UROLOGY (2016)
HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin
Justine Varinot et al.
VIRCHOWS ARCHIV (2016)
Strategies for developing Ki67 as a useful biomarker in breast cancer
Carsten Denkert et al.
BREAST (2015)
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2015)
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Roberta Ferraldeschi et al.
EUROPEAN UROLOGY (2015)
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen et al.
EUROPEAN UROLOGY (2015)
Glutathione S-transferase-pi protein expression in prostate cancer-not always a useful diagnostic tool
Verena Sailer et al.
HISTOPATHOLOGY (2015)
The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
Matthias Christgen et al.
HUMAN PATHOLOGY (2015)
Delta Np63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity
Katsunori Uchida et al.
HUMAN PATHOLOGY (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer
Diane Goltz et al.
PATHOLOGY (2015)
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
Cristina Villares Zabalza et al.
ONCOTARGET (2015)
Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies
F. Huber et al.
BRITISH JOURNAL OF CANCER (2015)
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer
Angela Queisser et al.
MODERN PATHOLOGY (2015)
Repeat Prostate Biopsy: Rationale, Indications, and Strategies
Umberto Capitanio et al.
EUROPEAN UROLOGY FOCUS (2015)
Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?
Verena Sailer et al.
APMIS (2014)
DNA methylation of PITX2 predicts poor survival in men with prostate cancer
Natasa Vasiljevic et al.
BIOMARKERS IN MEDICINE (2014)
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Eric A. Klein et al.
EUROPEAN UROLOGY (2014)
ERG Protein Expression in Diagnostic Specimens Is Associated with Increased Risk of Progression During Active Surveillance for Prostate Cancer
Kasper Drimer Berg et al.
EUROPEAN UROLOGY (2014)
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
Kirill Litovkin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
Alan W. Partin et al.
JOURNAL OF UROLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine
Emily Eva Holmes et al.
PLOS ONE (2014)
An expression signature at diagnosis to estimate prostate cancer patients' overall survival
Z. Peng et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Comparison of p40 (ΔNp63) and p63 expression in prostate tissues - which one is the superior diagnostic marker for basal cells?
Verena Sailer et al.
HISTOPATHOLOGY (2013)
Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
Stephen J. Freedland et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer Patients Following Radical Prostatectomy
Dimo Dietrich et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
An International Ki67 Reproducibility Study
Mei-Yin C. Polley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
Grant D. Stewart et al.
JOURNAL OF UROLOGY (2013)
Marked heterogeneity of ERG expression in large primary prostate cancers
Sarah Minner et al.
MODERN PATHOLOGY (2013)
Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer
Zsuzsanna Varga et al.
PLOS ONE (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin
Justine Varinot et al.
VIRCHOWS ARCHIV (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
Bruce J. Trock et al.
BJU INTERNATIONAL (2012)
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2012)
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
Andreas Pettersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Diagnostic and prognostic molecular biomarkers for prostate cancer
Glen Kristiansen
HISTOPATHOLOGY (2012)
ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
A. Marije Hoogland et al.
MODERN PATHOLOGY (2012)
Sunitinib Malate Provides Activity Against Murine Bladder Tumor Growth and Invasion in a Preclinical Orthotopic Model
Eddie Shu-yin Chan et al.
UROLOGY (2012)
The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Workup of Prostate Biopsies With Atypical Glands Suspicious for Cancer
Huiying He et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Andrea Sboner et al.
BMC MEDICAL GENOMICS (2010)
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker
Verena Tischler et al.
HISTOPATHOLOGY (2010)
Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer
Lionel L. Banez et al.
JOURNAL OF UROLOGY (2010)
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
Raquel Esgueva et al.
MODERN PATHOLOGY (2010)
GOLPH2 expression may serve as diagnostic marker in seminomas
Florian R. Fritzsche et al.
BMC UROLOGY (2010)
Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer
Donkena Krishna Vanaja et al.
CANCER INVESTIGATION (2009)
Golgi Phosphoprotein 2 (GOLPH2) Expression in Liver Tumors and Its Value as a Serum Marker in Hepatocellular Carcinomas
Marc-Oliver Riener et al.
HEPATOLOGY (2009)
DNA Methylation of the PITX2 Gene Promoter Region is a Strong independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy
Gunter Weiss et al.
JOURNAL OF UROLOGY (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 cases
Adeboye O. Osunkoya et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
Liesel M. FitzGerald et al.
BMC CANCER (2008)
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer:: implications for tissue-based diagnostics
G. Kristiansen et al.
BRITISH JOURNAL OF CANCER (2008)
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
Tohru Nakagawa et al.
PLOS ONE (2008)
GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus
Shuanzeng Wei et al.
PROSTATE (2008)
Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer
Sven Gunia et al.
VIRCHOWS ARCHIV (2008)
GOLPH2 expression in renal cell cancer
Florian Rudolf Fritzsche et al.
BMC Urology (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Oldest known case of metastasizing prostate carcinoma diagnosed in the skeleton of a 2,700-year-old Scythian King from Arzhan (Siberia, Russia)
Michael Schultz et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate
Todd Sheridan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis
Martine Schmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
Ming Yin et al.
DIAGNOSTIC PATHOLOGY (2007)
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?
F Ohl et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Small glandular proliferations on needle biopsies - Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion
M Herawi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci
PJ Bastian et al.
CLINICAL CANCER RESEARCH (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival
G Kristiansen et al.
JOURNAL OF PATHOLOGY (2005)
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer
S Edwards et al.
BRITISH JOURNAL OF CANCER (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of α-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia
CL Wu et al.
HUMAN PATHOLOGY (2004)
Prostein expression is highly restricted to normal and malignant prostate tissues
M Kalos et al.
PROSTATE (2004)
Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma
MS Tretiakova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
α-methylacyl-CoA racemase -: A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy
C Magi-Galluzzi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Expression of α-methylacyl-CoA racemase (P504S) in various malignant neoplasms and normal tissues:: A study of 761 cases
Z Jiang et al.
HUMAN PATHOLOGY (2003)
Alpha-methylacyl-CoA racemase - A novel tumor marker over-expressed in several human cancers and their precursor lesions
M Zhou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
P504S - A new molecular marker for the detection of prostate carcinoma
Z Jiang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
